Multivalent

Genyous Biomed Announces Private Placement Financing

... Company will leverage multivalent drug development platform, expand oncology pipelin... targets to treat complex chronic diseases. These multivalent therapies were designed using a systems biology st...ted (MFMT(TM)) drug development platform to create multivalent drugs designed to address the heterogeneous nature...

ImmunoVaccine Technologies Inc. to Acquire Immunotope Inc.

...arliest stages and to provide effective treatments that destroy tumors and prevent recurrence and metastasis. The company's lead product, the IMT-1012 multivalent therapeutic vaccine, is now being evaluated in a Phase I clinical trial at the Duke University Comprehensive Cancer Center in advanced-stage ovarian a...

Multivalent in Medical Technology

New Review on PROSTVAC(TM) Published by Key Investigators From NCI

...three areas: biodefence, cancer and infectious diseases. Bavarian Nordic's proprietary and patented technology MVA-BN(R) is one of the world's safest, multivalent vaccine vectors. Bavarian Nordic has ongoing contracts with the US government for the late-stage development and procurement of the company's third-ge...

Progress Against Malaria and Other Infectious Diseases Among Highlights at Annual Vaccine Conference

...rwritten by a grant from Merck & Co., Inc., honors the late Robert Austrian, MD, a University of Pennsylvania researcher who developed the first multivalent vaccine against pneumococcus bacteria. Also on Tuesday, the conference will announce the recipient of this year's Maurice R. Hilleman Early Stage Care...

BN ImmunoTherapeutics Updates on Phase I/II Studies With Breast Cancer Vaccine

... diseases. Bavarian Nordic's proprietary and patented technology, MVA-BN(R), has been demonstrated in clinical trials to be one of the world's safest, multivalent vaccine vectors. Bavarian Nordic has ongoing contracts with the US government for the late-stage development and procurement of the company's third-ge...

The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness

...three areas: biodefence, cancer and infectious diseases. Bavarian Nordic's proprietary and patented technology MVA-BN(R) is one of the world's safest, multivalent vaccine vectors. Bavarian Nordic has ongoing contracts with the U.S. government for the late-stage development and procurement of the company's third-...

Bavarian Nordic Reports Successful Safety Data From Phase II Study With IMVAMUNE(R)

...three areas: biodefence, cancer and infectious diseases. Bavarian Nordic's proprietary and patented technology MVA-BN(R) is one of the world's safest, multivalent vaccine vectors. Bavarian Nordic has ongoing contracts with the U.S. government for the late-stage development and procurement of the company's third-...

BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine

...three areas: biodefense, cancer and infectious diseases. Bavarian Nordic's proprietary and patented technology MVA-BN(R) is one of the world's safest, multivalent vaccine vectors. Bavarian Nordic has ongoing contracts with the US government for the late-stage development and procurement of the company's third-ge...

Bavarian Nordic Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine

...three areas: biodefence, cancer and infectious diseases. Bavarian Nordic's proprietary and patented technology MVA-BN(R) is one of the world's safest, multivalent vaccine vectors. Bavarian Nordic has ongoing contracts with the US government for the late-stage development and procurement of the company's third-ge...

Karolinska Institutet to Test Vical's Vaxfectin(R) Adjuvant With Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control

... evaluate Vical's Vaxfectin(R) adjuvant with the Biojector(R) 2000 needle-free injection system (Bioject Medical Technologies Inc., OTCBB: BJCT) for a multivalent preventive DNA vaccine against HIV. Professor Eric Sandstrom, M.D., Ph.D., Professor at the Karolinska Institutet, said, "The results from our initi...

Karolinska Institute to Test Vical's Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control

...o evaluate Vical's Vaxfectin(R) adjuvant with the Biojector(R) 2000 needle-free injection system (Bioject Medical Technologies Inc., OTCBB:BJCT) for a multivalent preventive DNA vaccine against HIV. Professor Eric Sandstrom, M.D., Ph.D., Professor at the Karolinska Institute, said, "The results from our initia...

BN ImmunoTherapeutics Starts Clinical Trials With Prostate Cancer Vaccine

... diseases. Bavarian Nordic's proprietary and patented technology, MVA-BN(R), has been demonstrated in clinical trials to be one of the world's safest, multivalent vaccine vectors. Bavarian Nordic has ongoing contracts with the US government for the late-stage development and procurement of the company's third-ge...

Multivalent in Medical Products

Cortisol EIA Hypertension / Cardiac Evaluation, Cardiovascular 012-MDKCO1 Stress Hormones

Description:... immobilized anti-rabbit antibodies. The horseradish peroxidase-labeled anti-ligand is added to the wells. During a second 30-minute incubation, multivalent anti-ligand labeled with enzyme binds to the bound ligand-labeled cortisol. Nonreactive sample components are removed by a washing step. A chromog...
Company:ALPCO Diagnostics

Multivalent in Biological News

Researchers identify new way the malaria parasite and red blood cells interact

...rasite binds to glycophorin B on the red blood cells. Down the road, the EBL-1 molecule could be used as a vaccine target against malaria as part of a multivalent vaccine, or vaccine cocktail," said principal investigator Ghislaine Mayer, Ph.D., assistant professor in the VCU Department of Biology. Additional...

DFG to establish 10 new collaborative research centers

...ndamental chemical and biological mechanisms and molecular architectures. In the long term, they hope their work will lead to the development of novel multivalent molecules that may be of great importance for use in inhibiting inflammation or providing protection against viral infections, as well as for optimisi...

Multivalent in Biological Technology

PROSTVAC(TM) Data Presented at the ASCO Meeting Demonstrates the Potential for Significant Increases in Life Expectancy in Late-Stage Prostate Cancer

...three areas: biodefence, cancer and infectious diseases. Bavarian Nordic's proprietary and patented technology MVA-BN(R) is one of the world's safest, multivalent vaccine vectors. Bavarian Nordic has ongoing contracts with the US government for the late-stage development and procurement of the company's third-ge...

The Court Supports Bavarian Nordic's Decision to Start Patent Infringement Case Against Oxford BioMedica

...three areas: biodefence, cancer and infectious diseases. Bavarian Nordic's proprietary and patented technology MVA-BN(R) is one of the world's safest, multivalent vaccine vectors. Bavarian Nordic has ongoing contracts with the US government for the late-stage development and procurement of the company's third-ge...

Bavarian Nordic Announces its Interim Report for the Period 1 January to 31 March 2009

...three areas: biodefence, cancer and infectious diseases. Bavarian Nordic's proprietary and patented technology MVA-BN(R) is one of the world's safest, multivalent vaccine vectors. Bavarian Nordic has ongoing contracts with the US government for the late-stage development and procurement of the company's third-ge...

Bavarian Nordic Publishes its Annual Results 2008

...three areas: biodefence, cancer and infectious diseases. Bavarian Nordic's proprietary and patented technology MVA-BN(R) is one of the world's safest, multivalent vaccine vectors. Bavarian Nordic has ongoing contracts with the US government for the late-stage development and procurement of the company's third-ge...

Bavarian Nordic Has Essentially Agreed a Pathway for the Licensure of IMVAMUNE(R) With the FDA After Successful End of Phase II Meeting

...three areas: biodefence, cancer and infectious diseases. Bavarian Nordic's proprietary and patented technology MVA-BN(R) is one of the world's safest, multivalent vaccine vectors. Bavarian Nordic has ongoing contracts with the US government for the late-stage development and procurement of the company's third-ge...

BN ImmunoTherapeutics Reports Further Data on PROSTVAC(TM)

... diseases. Bavarian Nordic's proprietary and patented technology, MVA-BN(R), has been demonstrated in clinical trials to be one of the world's safest, multivalent vaccine vectors. Bavarian Nordic has ongoing contracts with the US government for the late-stage development and procurement of the company's third-ge...

Omnitura Therapeutics Announces Private Placement Financing

...ill proceed with clinical trials of first-in-class multivalent therapies for cancer REDWOOD SHORES, Calif., ... II clinical development of Aneustat(TM), our lead multivalent cancer therapy," said Jeff Dao, President & CO...ps and facilitates the marketing of a new class of multivalent drugs for the treatment of cancer. Our mission is...

Bavarian Nordic's Case Against Oxford BioMedica

...three areas: biodefence, cancer and infectious diseases. Bavarian Nordic's proprietary and patented technology MVA-BN(R) is one of the world's safest, multivalent vaccine vectors. Bavarian Nordic has ongoing contracts with the US government for the late-stage development and procurement of the company's third-ge...

Bavarian Nordic Receives USD 25 Million Milestone Payment After Submission of Important IMVAMUNE(R) Data to The U.S. Health Authorities

...three areas: biodefence, cancer and infectious diseases. Bavarian Nordic's proprietary and patented technology MVA-BN(R) is one of the world's safest, multivalent vaccine vectors. Bavarian Nordic has ongoing contracts with the U.S. government for the late-stage development and procurement of the company's third-...

MonoSol Rx and Midatech Group Enter Collaboration Agreement to Unite Nanoparticle and Thin Film Drug Delivery Technologies

... diagnostics and other enabling applications. Among the attributes, Midatech's nanocells are water soluble; can present multiple ligands, allowing for multivalent drug or multi-drug delivery on a single particle; and can be delivered via different routes of administration due to their size and stability to enzym...

Multivalent in Biological Dictionary

P elements

...es used for genetic research. The P element gives rise to a... Phosphorus is the chemical element that has the symbol P and atomic number 15. A multivalent nonmetal of the nitrogen group, phosphorus is commonly found in inorganic phosphate rocks. Elemental phosphorus exists in two major forms - white phos...